Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 37kWORD 9k
26 June 2020
E-003779/2020
Question for written answer
to the Commission
Rule 138
Chris MacManus (GUE/NGL)
 Answer in writing 
 Subject: Myalgic encephalomyelitis

Myalgic encephalomyelitis (ME) affects around 25 000 people on the island of Ireland and two million across Europe.

In June 2020 the European Parliament passed a resolution on myalgic encephalomyelitis.

Can the Commission give a breakdown of the actions it now intends to take since the resolution was passed by Parliament?

Last updated: 13 July 2020Legal notice - Privacy policy